Please login to the form below

Not currently logged in
Email:
Password:

Bayer’s Barbara Jaszewski joins Lundbeck

She is appointed VP, global pricing and market access

Barbara Jaszewski, LundbeckLundbeck has named former Bayer director Barbara Jaszewski as its new VP, global pricing and market access.

Jaszewski has great experience in this type of role, serving most recently as director of global market access of Bayer Healthcare for the EMEA region and Canada.

This was her most senior role in a ten year career at Bayer that included several years in Canada as director of reimbursement.

Jaszewski has also spent time at GSK, where she was reimbursement strategist.

Lundbeck's senior VP, global product strategy and portfolio development Andrea Eggert commented on the appointment.

He said: “Barbara Jaszewski will play an important role in leading our efforts to further strengthen Lundbeck's commercial business processes, and will help our organisation support future product launches in the best way possible.”

Jaszewski's most pressing task will be to lead the launch of Selincro (nalmefene), which was recently recommended by the European Medicines Agency (EMA) to treat alcohol dependence.

In addition, Lundbeck also has Brintellix (vortioxetine) under review by the EMA, while a once-monthly version of schizophrenia drug Abilify (aripiprazole) is also due to launch during 2013.

14th January 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics